KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
R

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and Gemcitabine Adjuvant Therapy

By KU Hematology & Medical Oncology Review 2019 FEATURING Raed Al-Rajabi
By KU Hematology & Medical Oncology Review 2019 FEATURING Raed Al-Rajabi
849 views
August 21, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
Gastrointestinal
14:39

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

KU Hematology & Medical Oncology Review 2019

R. Al-Rajabi

849 views
16:20

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

KU Hematology & Medical Oncology Review 2019

R. Al-Rajabi

422 views
19:12

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

KU Hematology & Medical Oncology Review 2019

W. Sun

247 views
18:29

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

KU Hematology & Medical Oncology Review 2019

W. Sun

313 views